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Summary. The aim was to investigate the combined 
immunoexpression of p53, p21, bcl-2, bax, Rb and Ki67 
proteins in Hodgkin's lymphomas (HL) and correlate 
expression patterns with the histotype and the Epstein- 
Barr Virus (EBV) status. Paraffin-sections from 56 cases 
of HL (18 nodular sclerosis and 38 mixed cellularity) 
and from ten "reactive" lymph nodes were investigated. 
P53, p21, bcl-2, bax, Rb and Ki67 proteins were 
detected in Hodgkin and Reed-Sternberg (HRS) cells in 
35156,56156,24156, 23156,56156 and 56/56 cases of HL, 
respectively. No correlation was found between the 
expression of each protein and the EBV status or the 
histotype of HL. Comparison between p53 and p21 
staining revealed two patterns: a) p53+/p21+ (35 cases); 
and b) p53-/p21+ (21 cases). The pattern p53+/p21+ 
suggests wild type p53 protein able to induce the 
expression of p21 while the p53-/p21+ pattern suggests 
p53-independent p21 expression. These results are 
consistent with the interpretation that inactivating p53 
gene mutations may be rare in HL. Comparison between 
bcl-2 and bax staining showed a statistically significant 
relationship (p<0.001) for coexpression (19 cases) or 
absence of expression of both proteins (28 cases) in HRS 
cells. In contrast, bax expression was observed in most 
lymphoid cells in all "reactive" lymph nodes. Since the 
proapoptotic bax protein may act as tumour suppressor it 
is possible that the absence of this ,protein in HRS cells 
in a substantial proportion of HL may confer growth 
advantage and play a role in their pathogenesis. This 
could suggest bax gene alterations in some HL since in 
other studies acute lymphoblastic leukaemia cell lines 
demonstrate bax gene mutations with loss of bax 
immunoexpression. Another possibility is that reduced 
bax expression may be due to post transcriptional 
regulation, as was described in lymphoma cell lines. 
Comparison between Rb and Ki67 staining disclosed 
two main deviations from the normal parallel 
relationship in reactive lymph nodes: a) 2 cases with low 
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Rb and high Ki67 expression possibly reflecting loss of 
Rb expression due to chromosome loss or to other 
abnormalities in the structure or the expression of Rb 
gene; and b) 9 cases with high RB and low Ki67 possible 
reflecting an attempt of Rb protein in excess to induce 
cell cycle arrest. Taken together, our findings provide 
combined immunohistological evidence for deregulated 
expression of cell-cycle and apoptosis-related proteins, 
that may play a role in the pathogenesis of HL. 
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Introduction 
Despite the enormous variations in human tumour 
types a common theme in oncogenesis is  the 
perturbation of the complex network proliferationlcell- 
cycle arrest/differentiation/apoptosis. Analysis of the 
proteins involved in this network should help to clarify 
the multiple pathways of oncogenesis. p53 has a central 
role in the regulation of the cell-cycle and the apoptosis 
(Miyashita and Reed, 1994; Cox, 1997; Morente et al., 
1997; Evan and Littlewood, 1998; Prives and Hall, 
1999). There is evidence that the levels of p53 a) are 
regulated by its interaction with mdm2, b) are modified 
after cellular stress and c) are altered by a stress signal 
independent pathway in which the product of the 
alternative reading frame (ARF) of the P16 locus is 
induced and this leads to abrogation of mdm2-targeted 
destabilization of p53 (Prives and Hall, 1999). Wild-type 
(wt) p53 transcriptionally upregulates p2llwafl protein 
which inactivates the cyclin/cyclin-dependent-kinase 
(CDK) complexes resulting in inhibition of 
Retinoblastoma (Rb) protein phosphorylation and 
blocking the cell-cycle progression in the G1-S 
transition (El Deiry et al., 1993; Cordon-Cardo and 
Richon, 1994; Waga et al., 1994; Elledge, 1996, Cox, 
1997; Prives and Hall, 1999). In addition, p2l lwafl  
protein blocks the action of proliferating cell nuclear 
antigen (PCNA), impeding DNA replication (Waga et 








